US 11427816
Cancer treatment through RLIP76 partial depletion
granted A61PA61P35/00
Quick answer
US patent 11427816 (Cancer treatment through RLIP76 partial depletion) held by The Board of Regents of the University of Texas System expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P35/00